OrthoPediatrics (NASDAQ:KIDS) Announces Earnings Results, Beats Expectations By $0.04 EPS

OrthoPediatrics (NASDAQ:KIDS) announced its earnings results on Tuesday. The company reported ($0.29) EPS for the quarter, topping the consensus estimate of ($0.33) by $0.04, Zacks reports. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. OrthoPediatrics updated its FY 2025 guidance to EPS.

OrthoPediatrics Stock Down 1.1 %

NASDAQ:KIDS traded down $0.26 on Tuesday, hitting $22.89. 237,721 shares of the company’s stock were exchanged, compared to its average volume of 315,790. The company has a market cap of $554.30 million, a P/E ratio of -18.61 and a beta of 1.14. The firm has a 50-day moving average price of $24.38 and a 200-day moving average price of $25.97. The company has a debt-to-equity ratio of 0.19, a current ratio of 7.17 and a quick ratio of 3.68. OrthoPediatrics has a 52 week low of $21.02 and a 52 week high of $35.99.

Analysts Set New Price Targets

KIDS has been the topic of several research reports. Truist Financial cut their price objective on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th. Needham & Company LLC reissued a “buy” rating and issued a $42.00 price target on shares of OrthoPediatrics in a research note on Tuesday, January 14th.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.